Drug Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

Drug Name CA-4948
Trade Name
Synonyms CA4948|CA 4948
Drug Descriptions

CA-4948 inhibits IRAK4, thereby blocking TLR and IL-1R signaling, potentially resulting in tumor regression (PMID: 33335659).

DrugClasses IRAK4 Inhibitor 5
CAS Registry Number 1801343-74-7
NCIT ID C148455

Filtering

  • Case insensitive filtering will display rows where any text in any cell matches the filter term
  • Simple literal full or partial string matches
  • Separate multiple filter terms with a spaces, order doesn't matter (a b c and c b a are equivalent )
  • Filtering will only apply to rows that are already loaded on the page, filtering has no impact on query parameters
  • Use quotes to match a longer phrase which contains spaces "mtor c1483f"

Sorting

  • Generally, the default sort order for tables is set to be first column ascending, however, specific tables may set a different default sort order.
  • Click on any column header arrows to sort by that column
  • Hold down the Shift key and click multiple columns to sort by more than one column, be sure to set ascending or descending order for a given column, before moving on to the next column.

Therapy Name Drugs Efficacy Evidence Clinical Trials
CA-4948 CA-4948 0 3
CA-4948 + Fluorouracil + Leucovorin + Nivolumab + Oxaliplatin CA-4948 Fluorouracil Leucovorin Nivolumab Oxaliplatin 0 1
CA-4948 + Fluorouracil + Leucovorin + Oxaliplatin + Pembrolizumab + Trastuzumab CA-4948 Fluorouracil Leucovorin Oxaliplatin Pembrolizumab Trastuzumab 0 1
CA-4948 + Ibrutinib CA-4948 Ibrutinib 0 0
CA-4948 + Idelalisib CA-4948 Idelalisib 0 0
CA-4948 + Venetoclax CA-4948 Venetoclax 0 0


Additional content available in CKB BOOST